Brought to you by 
Sequencing company ReadCoor raises $23mm in Series A round
23 Apr 2021
Executive Summary
ReadCoor Inc. (imaging platform of gene locations) raised $23mm in its Series A financing led by Decheng Capital. Lilly Asia Ventures, Vivo Capital, and Hansjorg Wyss also participated. Members from Decheng and Vivo joined the company’s board.
Deal Industry
- In Vitro Diagnostics
- Pharmaceuticals
-
Biotechnology
-
Drug Discovery Tools
- Genomics-Proteomics
-
Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Financing
- Spin-Off
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Sequencing company ReadCoor raises $23mm in Series A round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice